🔍

Indogulf Cropsciences Limited (IGCL)

📊 NSE: IGCL 🏢 Pesticides & Agrochemicals 📅 Last Updated: 11/13/2025 15:25

📢 Recent Corporate Announcements

Indogulf Cropsciences Issues Notice for 34th AGM Scheduled on Sept 24, 2026

🟡 NEUTRAL ⭐ 2/10

ROUTINE 📅 01 Sep 2026, 05:24 PM

Indogulf Cropsciences Limited has issued notice for its 34th Annual General Meeting (AGM) to be held on September 24, 2026, via video conferencing. The company also released its Integrated Annual Report covering the financial year 2025-26. Disclosures in the report detail standalone borrowings of INR 1,684.11 million and trade payables of INR 1,268.14 million as of March 31, 2026. This is a standard compliance filing ahead of the shareholder meeting.

34th Annual General Meeting scheduled for Thursday, September 24, 2026, at 12:00 Noon IST
Meeting to be conducted entirely via two-way video conferencing/audio-visual means
Standalone borrowings stood at INR 1,684.11 million as of March 31, 2026 (vs INR 1,808.82 million in FY25)
Trade payables stood at INR 1,268.14 million as of March 31, 2026, including INR 123.69 million to MSME entities

💡 Shareholders should note the AGM date of September 24, 2026, and review the detailed Annual Report for statutory resolutions and operational commentary.

Indogulf Cropsciences Reschedules Mumbai Investor Meetings to Sept 1-2, 2026

🟡 NEUTRAL ⭐ 2/10

ROUTINE 📅 27 Aug 2026, 12:59 PM

Indogulf Cropsciences Limited has notified exchanges of a revised schedule for physical investor and analyst interactions. The in-person meetings, originally planned for August 31 and September 1, 2026, have been rescheduled to September 1 and September 2, 2026, in Mumbai starting at 10:00 AM IST. The company stated discussions will be based strictly on publicly available information with no unpublished price-sensitive information shared.

Investor/Analyst meetings rescheduled to September 1st and September 2nd, 2026
Original dates were scheduled for August 31st and September 1st, 2026
Meeting format is physical/in-person in Mumbai starting at 10:00 A.M. IST onwards
Discussion strictly based on generally available information without UPSI

💡 Track post-meet investor presentations or disclosure transcripts filed with the exchanges for any qualitative updates on capacity expansion and operational performance.

Indogulf Cropsciences Schedules Analyst & Investor Meetings in Mumbai on Aug 31-Sep 1, 2026

🟡 NEUTRAL ⭐ 2/10

ROUTINE 📅 26 Aug 2026, 05:46 PM

Indogulf Cropsciences Limited has notified the exchanges regarding scheduled physical meetings with analysts and institutional investors in Mumbai. The one-on-one and group interactions are scheduled for August 31 and September 1, 2026, starting at 10:00 AM IST. The company confirmed that discussions will be strictly based on publicly available information without sharing unpublished price-sensitive information.

Interaction dates scheduled for August 31st & 1st September, 2026
Meetings will begin from 10:00 A.M (IST) onwards in Mumbai
Format includes both physical in-person one-on-one and group meetings
Management confirmed no Unpublished Price Sensitive Information (UPSI) will be discussed

💡 Monitor post-meet disclosures or presentation filings for any operational insights or strategic management updates discussed during the meetings.

High Court Quashes ₹8.48 Cr GST Demand; IGCL to Receive ~₹8.11 Cr Tax Refund

🟢 POSITIVE ⭐ 5/10

LEGAL 📅 21 Aug 2026, 12:39 PM

The Hon'ble High Court of Punjab and Haryana has ruled in favor of Indogulf Cropsciences Limited, quashing a GST show cause notice and order-in-original demanding recovery of ₹6,93,12,901 along with interest of ₹1,54,58,004 (total ~₹8.48 crore). The dispute pertained to an alleged erroneous IGST refund under Rule 96(10). Following this order, the company's prior voluntary deposit of ₹6,56,07,859 (IGST) and ₹1,54,58,004 (interest)—totaling ~₹8.11 crore—will be refunded back to IGCL in due course.

Punjab & Haryana High Court quashed tax demand of ₹6,93,12,901 and interest of ₹1,54,58,004.
IGCL to receive a refund of ₹8,10,65,863 (₹6.56 cr IGST + ₹1.55 cr interest) previously deposited voluntarily.
Allegation by Central GST Commissionerate Rohtak concerned Rule 96(10) IGST refund recovery.
Final order dated August 14, 2026 was received by the company on August 20, 2026.

💡 Track the timeline of the actual cash inflow from the tax refund and its recognition in subsequent quarterly financials.

Indogulf Cropsciences Releases Q1 FY27 Concall Transcript: Revenue at ₹168.5 Cr, Gross Margin at 28%

🟡 NEUTRAL ⭐ 3/10

EARNINGS 📅 21 Aug 2026, 11:53 AM

Indogulf Cropsciences submitted the transcript for its Q1 FY27 earnings conference call held on August 18, 2026. Consolidated revenue for the quarter stood at ₹168.5 crore, marking an 11% YoY decline due to delayed and uneven monsoons pushing Kharif demand into subsequent quarters. However, gross margin expanded to 28% (up from 22% in Q1 FY26) and EBITDA margin improved to 5.7% (up from 5.2%). Operational capacity utilization improved significantly to 70% during the quarter compared to 52% in FY26.

Q1 FY27 revenue declined 11% YoY to ₹168.5 crore (vs ₹189.4 crore in Q1 FY26) due to delayed Kharif sowing
Gross margins improved 600 bps YoY to 28%, while EBITDA margin improved to 5.7% from 5.2%
Capacity utilization rose to 70% during Q1 FY27 compared to 52% in FY26
Captive technical manufacturing supplied approximately 34% of crop protection requirements
Global regulatory base expanded to 189 registrations, with >120 currently active

💡 Track Q2 FY27 revenue recovery as deferred Kharif demand materializes, alongside the progress of international registrations and the planned 50% capacity expansion at Sonipat.

IGCL Releases Audio Recording of Q1 FY27 Analyst and Investor Conference Call

🟡 NEUTRAL ⭐ 2/10

ROUTINE 📅 18 Aug 2026, 01:05 PM

Indogulf Cropsciences Limited has made available the audio recording link for its earnings conference call held on August 18, 2026. The call focused on the un-audited standalone and consolidated financial results for Q1 FY2026-27. For context, the company reported revenue of ₹168.55 crore and net profit of ₹2.41 crore in the June 2026 quarter. This filing represents a routine statutory disclosure under SEBI LODR Regulation 30.

Audio recording link submitted for investor conference call held on August 18, 2026
Discussion covered un-audited standalone and consolidated results for Q1 FY2026-27
Filing submitted in compliance with Regulation 30 of SEBI LODR Regulations

💡 Investors can access the audio recording or upcoming written transcripts to review management commentary regarding capacity additions and demand trends.

Indogulf Cropsciences Submits Revised Q1 FY27 Earnings Presentation; Insecticides Form 64% of Mix

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 18 Aug 2026, 11:16 AM

Indogulf Cropsciences Limited submitted a revised Q1 FY27 earnings call presentation to rectify clerical errors from its earlier filing on August 14, 2026. In Q1 FY27, insecticides formed the largest share of the product mix at 64%, followed by herbicides at 25%, fungicides at 7%, and fertilizers at 4%. The company highlighted its footprint spanning 4 manufacturing units, a portfolio of 300+ products, 6 patents, and distribution across 36+ export destinations.

Q1 FY27 product mix comprised 64% Insecticides, 25% Herbicides, 7% Fungicides, and 4% Fertilizers.
Global operational presence covers 36+ export countries supported by 189 regulatory registrations.
Domestic reach comprises 7,500+ distributors, 33 stock depots, and engagement with 100,000+ farmers.
The presentation rectifies inadvertent clerical errors in the previous submission dated August 14, 2026.

💡 Track execution on international registrations (such as Brazil and Africa) and quarterly margin improvement following Q1 FY27 revenue of Rs 168.55 Cr.

IGCL Q1 FY27: Revenue declines 11% to ₹168.5 Cr; Gross Margins expand to 28%

🔴 NEGATIVE ⭐ 7/10

EARNINGS 📅 14 Aug 2026, 01:15 PM

Indogulf Cropsciences (IGCL) reported a challenging Q1 FY27 with revenue declining 11% YoY to ₹168.5 crore, primarily due to erratic monsoon patterns impacting sales volumes. Despite the top-line contraction, the company achieved a significant gross margin expansion to 28.0% from 22.0% in Q1 FY26, driven by a shift toward differentiated products. However, Net Profit (PAT) fell 38% YoY to ₹2.4 crore, weighed down by higher operating expenses and finance costs. The company remains focused on its 50% capacity expansion at the Sonipat plant, which is slated for completion by Q1 FY2027.

Revenue from operations fell 11% YoY to ₹168.5 crore in Q1 FY27 from ₹189.4 crore.
Gross Profit margin improved by 600 basis points YoY to 28.0% through better product mix.
Profit After Tax (PAT) decreased 38% YoY to ₹2.4 crore compared to ₹3.9 crore in the previous year.
B2C segment contributed 47% of total revenue, while B2B and Exports accounted for 31% and 13% respectively.
Planned 50% capacity expansion at the Sonipat plant is on track for completion by Q1 FY2027.

💡 Monitor the execution timeline of the Sonipat plant expansion and the recovery of sales volumes in the upcoming quarters, as Q1 was heavily impacted by weather conditions. Watch for the growth in the 'Biologicals' segment, which currently contributes only 3% to revenue but is a high-margin focus area.

₹1,685 Mn Revenue in Q1 FY27: IGCL Reports 12% QoQ Growth but 38% YoY PAT Decline

🔴 NEGATIVE ⭐ 6/10

EARNINGS 📅 13 Aug 2026, 04:26 PM

Indogulf Cropsciences (IGCL) reported a sequential revenue recovery of 12% to ₹168.5 cr in Q1 FY27, although revenue declined 11% on a year-on-year basis. Profit After Tax (PAT) saw a sharp contraction of 38% YoY, falling to ₹2.4 cr, with net margins thinning to just 1%. A positive operational highlight is the increase in manufacturing capacity utilization to 70%, up from 52% in FY26. The company is currently focusing on its Barwasni facility expansion and diversifying into biologicals to mitigate macro headwinds.

Revenue from operations stood at ₹1,685 million, reflecting a 12% sequential growth but an 11% YoY decline.
Profit After Tax (PAT) decreased by 38% YoY to ₹24 million from ₹39 million in the year-ago quarter.
Manufacturing capacity utilization improved significantly to 70% in Q1 FY27 compared to 52% for the full year FY26.
Gross profit grew 12% YoY to ₹466 million, with gross margins improving to 28% due to better product mix.
EBITDA margins stood at 6%, a slight improvement of 47 bps YoY, but a sharp drop from 14% in Q4 FY26.

💡 Investors should monitor the execution timeline of the Barwasni facility expansion and whether the improved capacity utilization (70%) leads to better operating leverage in the high-growth Q2 period. The significant gap between gross margins (28%) and net margins (1%) warrants a close watch on rising operational and branding expenses.

IGCL schedules Q1 FY27 earnings conference call for August 18, 2026

🟡 NEUTRAL ⭐ 2/10

ROUTINE 📅 13 Aug 2026, 11:52 AM

Indogulf Cropsciences Limited (IGCL) has scheduled its Q1 FY 2026-27 earnings conference call for August 18, 2026, at 11:00 AM IST. The management, including the Managing Director and CFO, will discuss the company's performance following a fiscal year (FY26) where revenue reached ₹2,725.76 crore. Investors will likely seek updates on the 50% capacity expansion at the Sonipat plant and the performance of 12 new products launched in H1 FY26. This call is a standard procedure for the company to engage with institutional investors and analysts.

Earnings conference call scheduled for August 18, 2026, at 11:00 AM IST
Management representation includes the Managing Director and Chief Financial Officer
Discussion to cover Q1 FY27 performance following FY26 annual revenue of ₹2,725.76 crore
Company is currently executing a 50% capacity expansion at its Sonipat plant due by FY2027
Call will likely address the 20% expected growth rate target and recent product launches

💡 Monitor the post-call transcript or recording for management commentary on the execution timeline of the Sonipat expansion and the impact of monsoon patterns on Q1 sales volumes.

IGCL Q1 FY27 Results: Consolidated Revenue at ₹168.5 Cr, PAT down 37.6% YoY to ₹2.4 Cr

🔴 NEGATIVE ⭐ 6/10

EARNINGS 📅 12 Aug 2026, 11:53 AM

Indogulf Cropsciences Limited (IGCL) reported a consolidated revenue of ₹168.54 cr for Q1 FY27, representing an 11% decline from ₹189.37 cr in the same quarter last year. Net profit (PAT) fell significantly by 37.6% YoY to ₹2.41 cr, down from ₹3.87 cr. The company faced severe margin pressure, with total expenses accounting for 98.6% of operational revenue, resulting in a thin Profit Before Tax (PBT) margin of 1.85%. These results highlight the extreme seasonality of the business, where Q1 typically contributes a small fraction of annual revenue.

Consolidated Revenue from operations decreased 11% YoY to ₹168.54 cr from ₹189.37 cr.
Consolidated Net Profit (PAT) dropped 37.6% YoY to ₹2.41 cr compared to ₹3.87 cr in Q1 FY26.
Total expenses for the quarter stood at ₹166.27 cr, nearly matching the total income of ₹169.43 cr.
Basic Earnings Per Share (EPS) for the quarter declined to ₹0.38 from ₹0.80 in the year-ago period.
Finance costs for the quarter were ₹4.51 cr, impacting the bottom line.

💡 Investors should monitor the execution of the 50% capacity expansion at the Sonipat plant, which is critical for scaling beyond the current seasonal peaks, and track the revenue contribution from the 12 new products launched in H1 FY26.

IGCL Reports 100% Demat Holding in Routine June 2026 Compliance Filing

🟡 NEUTRAL ⭐ 2/10

ROUTINE 📅 10 Jul 2026, 11:14 AM

Indogulf Cropsciences Limited (IGCL) has submitted its quarterly compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018. The Registrar and Transfer Agent, Bigshare Services Pvt Ltd, confirmed that no requests for dematerialization or rematerialization were received during the quarter ended June 30, 2026. This is because the entire shareholding of the company is already maintained in dematerialized form. This is a standard administrative disclosure with no impact on business fundamentals.

Quarterly compliance certificate filed for the period ending June 30, 2026
Confirmed that 100% of the company's shares are currently held in demat form
Reported 0 requests for dematerialization or rematerialization during the quarter
Certificate issued by Bigshare Services Pvt Ltd, the company's Registrar and Transfer Agent

💡 Investors should treat this as a routine regulatory update; focus remains on the 50% capacity expansion progress at the Sonipat plant scheduled for FY2027.

MD Sanjay Aggarwal Conferred with 17th Visionary Leadership Award 2026

🟡 NEUTRAL ⭐ 2/10

MANAGEMENT 📅 09 Jul 2026, 10:45 AM

Indogulf Cropsciences' Managing Director, Shri Sanjay Aggarwal, has been awarded the 17th Visionary Leadership Award 2026 by the Agriculture Leadership Awards Committee. The award, presented by the Union Minister of Defence on July 8, 2026, recognizes leadership in sustainable crop protection and innovation. While positive for brand reputation, this is a non-material event regarding financial performance. Investors should remain focused on the company's ongoing 50% capacity expansion at its Sonipat plant scheduled for completion by FY2027.

Managing Director Sanjay Aggarwal received the 17th Visionary Leadership Award 2026
Company maintains a diversified portfolio of 300+ registered products
Operations currently span 34+ countries with 990+ registrations
Planned 50% capacity expansion at Sonipat plant remains the primary growth driver for FY2027

💡 Focus on operational milestones such as the 50% capacity expansion at Sonipat and the revenue contribution from the 12 new products launched in H1 FY26.

IGCL to Close Trading Window from July 1, 2026 for Q1 FY27 Financial Results

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 24 Jun 2026, 04:27 PM

Indogulf Cropsciences Limited has notified the exchanges regarding the closure of its trading window effective July 1, 2026. This closure is mandatory under SEBI's Insider Trading regulations ahead of the board meeting to approve un-audited financial results for the quarter ending June 30, 2026. The restriction applies to all designated persons, including directors and key management personnel. The window will reopen 48 hours after the results are officially declared to the public.

Trading window closure begins on July 01, 2026
Purpose is the approval of un-audited financial results for the quarter ended June 30, 2026
Restriction remains in place until 48 hours after the results become generally available
Applies to all designated persons and their immediate relatives

💡 This is a standard regulatory procedure; investors should wait for the actual earnings release to evaluate the company's financial health.

Indogulf Cropsciences to Meet Institutional Investors on June 18-19, 2026

🟢 POSITIVE ⭐ 4/10

ROUTINE 📅 15 Jun 2026, 05:58 PM

Indogulf Cropsciences Limited (IGCL) has scheduled a series of one-on-one and group meetings with several institutional investors and analysts on June 18 and 19, 2026, in Mumbai. The company will interact with prominent firms including Abakkus Asset Managers, Emkay Global, and Genuity Capital, among others. These discussions will be based on generally available information to ensure compliance with SEBI regulations regarding Unpublished Price Sensitive Information (UPSI). Such interactions typically indicate management's effort to increase transparency and institutional footprint.

Management scheduled to meet with 7 institutional entities including Abakkus Asset Managers and Emkay Global.
Meetings are set for June 18 and June 19, 2026, in Mumbai via one-on-one and group formats.
The interaction aims to discuss company performance based on publicly available data without disclosing UPSI.
Participating firms include Arjav Partners, Finavenue, Amrut Advisors, and Svan Investments.

💡 Investors should watch for any investor presentations or transcripts released following these meetings for insights into the company's growth outlook. The interest from reputable firms like Abakkus suggests increasing institutional attention on the stock.

View All IGCL Announcements on Live Market Tracking →

💰 Financial Performance

Revenue Growth by Segment

In H1 FY26, B2B Domestic revenue grew 23.6% to INR 1,863 million, B2C Domestic revenue grew 19% to INR 2,320 million, and Exports grew 6.4% to INR 334 million. Total H1 FY26 revenue reached INR 4,377 million, a 20% YoY increase.

Geographic Revenue Split

The company saw significant growth in H1 FY26 across key Indian states: Haryana (+60%), Maharashtra (+26%), Uttar Pradesh (+25%), and Andhra Pradesh (+22%). Exports currently contribute approximately 7.6% of H1 FY26 revenue.

Profitability Margins

Gross margins improved to 26.2% in H1 FY26 from 24.3% in H1 FY25. PAT margins increased to 7.3% in H1 FY26 compared to 6.8% in H1 FY25, driven by higher B2C sales and better operating leverage.

EBITDA Margin

EBITDA margin for H1 FY26 stood at 9.6%, up from 9.1% YoY. Q2 FY26 EBITDA margin was significantly higher at 12.9% (INR 320 million) due to seasonal peak demand for B2C products like Orion Gold.

Capital Expenditure

The company is investing INR 70 crore in a new formulation plant at Sonipat to increase capacity by 50% and INR 14 crore for a new Dry Flowable (DF) unit, both expected to commence operations in Q1 FY2027.

Credit Rating & Borrowing

Credit rating was upgraded in Q2 FY26 to [ICRA]A- (Stable) and [ICRA]A1. Interest coverage ratio was 4.4x in FY2025, with debt/equity improving to 0.5x post-IPO debt repayment.

⚙️ Operational Drivers

Raw Materials

Technicals and chemical intermediates for pesticides and fertilizers; imports account for 25-30% of total raw material requirements.

Import Sources

Approximately 25-30% of raw materials are imported from international markets to support the technical and formulation units.

Capacity Expansion

Current operations span 4 manufacturing units across 20 acres. Planned expansion at Sonipat will add 50% to existing formulation capacity by Q1 FY2027 to meet growing domestic demand.

Raw Material Costs

Raw material costs are subject to volatility in global commodity prices and forex rates; the company is pursuing backward integration into technical manufacturing to secure supply and expand margins.

Manufacturing Efficiency

The company is implementing SAP and automation to streamline operations and leverage economies of scale as it expands production capacity.

Logistics & Distribution

The company utilizes a wide distribution network for its B2C segment, with a specific focus on increasing the dealer presence of its subsidiary Abhiprakash Globus Private Limited (AGPL).

📈 Strategic Growth

Expected Growth Rate

20%

Growth Strategy

Growth will be driven by a 50% capacity expansion at the Sonipat plant by FY2027, the launch of 12 new products in H1 FY26 which already contribute 3% to revenue, and a multi-brand strategy where the Mascot Giraffe brand (AGPL) now contributes 9% of revenue.

Products & Services

Insecticides, fungicides, herbicides, plant growth regulators, crop nutrients, and biologicals.

Brand Portfolio

Orion Gold, Mascot Giraffe (under subsidiary AGPL).

New Products/Services

12 new products launched in H1 FY26 across categories, contributing 3% to Q2 FY26 revenues.

Market Expansion

Expanding B2C presence in high-growth states like Haryana and Maharashtra and increasing penetration in European export markets.

Strategic Alliances

Maintains long-term relationships with international technical manufacturers for raw material sourcing.

🌍 External Factors

Industry Trends

The industry is growing but faces disruption from bio-products and stricter environmental safety norms. IGCL is positioning itself by expanding its 'Biologicals' segment, which grew to INR 209 million in H1 FY26.

Competitive Landscape

Intense competition from both domestic players and multinational corporations in the fragmented agrochemical space.

Competitive Moat

Sustainable advantages include 30+ years of promoter experience, a massive portfolio of 300+ registered products, and an established B2C dealer network that creates high entry barriers.

Macro Economic Sensitivity

Highly sensitive to agro-climatic conditions (monsoon) and government agricultural policies.

Consumer Behavior

Farmers are increasingly shifting toward bio-stimulants and safer product formulations due to evolving safety policies.

Geopolitical Risks

Trade barriers or regulatory changes in Europe could impact the company's export growth strategy.

⚖️ Regulatory & Governance

Industry Regulations

The Government of India banned 4 pesticides (Dicofol, Dinocap, Methomyl, Monocrotophos) in Oct 2023; 24 more remain under regulatory review, creating potential portfolio risk.